Literature DB >> 8062281

A frequent alteration of p53 gene in carcinoma in adenoma of colon.

M Ohue1, N Tomita, T Monden, M Fujita, M Fukunaga, K Takami, I Yana, T Ohnishi, T Enomoto, M Inoue.   

Abstract

In general, colorectal carcinoma is thought to originate mainly from adenoma, and this pathway is called the adenoma-carcinoma sequence. Carcinoma in adenoma is an appropriate model for analysis of this mechanism, because adenoma and carcinoma tissues coexist in the same polyp and the carcinoma is thought to have originated from the surrounding adenoma. Expression of the p53 protein was analyzed in 36 cases of carcinoma in adenoma in the colon by immunohistochemistry using an anti-human p53 monoclonal antibody (PAb1801). Alterations of the p53 gene were analyzed by the polymerase chain reaction for microanalysis of normal mucosa, adenoma, and carcinoma from histological slides. Mutations were assessed by the polymerase chain reaction-single strand conformation polymorphism analysis and identified by DNA sequencing in some cases. Loss of heterozygosity was studied by polymerase chain reaction-restriction fragment length polymorphism analysis. Positive staining for p53 was detected in three (8%) of 37 adenomas and 20 (53%) of 38 focal carcinomas. One (7%) of 15 adenomas with mild dysplasia, three (14%) of 22 adenomas with moderate dysplasia, and 16 (42%) of 38 focal carcinomas had a mutation in exon 5 through exon 8 of the p53 gene. As for allelic loss in the p53 gene locus, only one adenoma with moderate dysplasia had loss of heterozygosity, whereas six (40%) of 15 focal carcinomas had loss of heterozygosity. Of those tumors (3 of 37 adenomas and 20 of 38 focal carcinomas) that reacted with PAb1801, 78% (18 of 23) showed genetic alterations. Among 52 tumors which showed negative staining, five tumors had a p53 mutation and four of them were nonsense mutations. Putting all of these results together, 71% (24 of 34) of the cases underwent p53 gene and protein alterations during the conversion from adenoma to focal carcinoma. These data clearly indicate that genetic alterations of p53 are involved mainly in the malignant transformation from adenoma to focal carcinoma in colon carcinogenesis. In addition, some cases show heterogeneity of the p53 gene in carcinoma in adenoma of the colon. There may be other pathways than p53 responsible for malignant change in the colon.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8062281

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

1.  Prognostic value of immunohistochemistry for p53 in primary soft-tissue sarcomas: a multivariate analysis of five antibodies.

Authors:  P Würl; H Taubert; A Meye; D Berger; C Lautenschläger; H J Holzhausen; H Schmidt; H Kalthoff; F W Rath; H Dralle
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

Review 2.  Biology of colorectal cancer in ulcerative colitis.

Authors:  B A Lashner; B D Shapiro
Journal:  J Gastrointest Surg       Date:  1998 Jul-Aug       Impact factor: 3.452

3.  Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.

Authors:  Janine G Einspahr; Maria Elena Martinez; Ruiyun Jiang; Chiu-Hsieh Hsu; Asif Rashid; Achyut K Bhattacharrya; Dennis J Ahnen; Elizabeth T Jacobs; P Scott Houlihan; C Renee Webb; David S Alberts; Stanley R Hamilton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-08       Impact factor: 4.254

4.  Retaining cell-cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer.

Authors:  Jumpei Kondo; Hiroko Endo; Hiroaki Okuyama; Osamu Ishikawa; Hiroyasu Iishi; Masahiko Tsujii; Masayuki Ohue; Masahiro Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-28       Impact factor: 11.205

5.  Establishment and characterization of a murine xenograft model of appendiceal mucinous adenocarcinoma.

Authors:  Arun A Mavanur; Vamsi Parimi; Mark O'Malley; Marina Nikiforova; David L Bartlett; Jon M Davison
Journal:  Int J Exp Pathol       Date:  2010-06-25       Impact factor: 1.925

6.  Microsatellite analysis of sporadic flat and depressed lesions of the colon.

Authors:  Timothy P Kinney; Nina Merel; John Hart; Loren Joseph; Irving Waxman
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

7.  Molecular markers of carcinogenesis for risk stratification of individuals with colorectal polyps: a case-control study.

Authors:  Samir Gupta; Han Sun; Sang Yi; Joy Storm; Guanghua Xiao; Bijal A Balasubramanian; Song Zhang; Raheela Ashfaq; Don C Rockey
Journal:  Cancer Prev Res (Phila)       Date:  2014-08-04

8.  Lineage analysis of early and advanced tubular adenocarcinomas of the stomach: continuous or discontinuous?

Authors:  Takahisa Nakayama; Zhi-Qiang Ling; Ken-ichi Mukaisho; Takanori Hattori; Hiroyuki Sugihara
Journal:  BMC Cancer       Date:  2010-06-21       Impact factor: 4.430

9.  p53 overexpression in flat serrated adenomas and flat tubular adenomas of the colorectal mucosa.

Authors:  C A Rubio; M Rodensjö
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

10.  The genomics of colorectal cancer: state of the art.

Authors:  Andrew D Beggs; Shirley V Hodgson
Journal:  Curr Genomics       Date:  2008-03       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.